ATE59960T1 - Theophyllintabletten mit verzoegerter freigabe. - Google Patents

Theophyllintabletten mit verzoegerter freigabe.

Info

Publication number
ATE59960T1
ATE59960T1 AT86115815T AT86115815T ATE59960T1 AT E59960 T1 ATE59960 T1 AT E59960T1 AT 86115815 T AT86115815 T AT 86115815T AT 86115815 T AT86115815 T AT 86115815T AT E59960 T1 ATE59960 T1 AT E59960T1
Authority
AT
Austria
Prior art keywords
delayed release
release theophylline
theophylline tablets
tablets
relates
Prior art date
Application number
AT86115815T
Other languages
English (en)
Inventor
Michael Friedman
Meir Bialer
Hussein Ziad
Original Assignee
Yissum Res Dev Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Res Dev Co filed Critical Yissum Res Dev Co
Application granted granted Critical
Publication of ATE59960T1 publication Critical patent/ATE59960T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2063Proteins, e.g. gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
AT86115815T 1986-03-03 1986-11-14 Theophyllintabletten mit verzoegerter freigabe. ATE59960T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL78017A IL78017A (en) 1986-03-03 1986-03-03 Sustained release tablets of theophylline
EP86115815A EP0235363B1 (de) 1986-03-03 1986-11-14 Theophyllintabletten mit verzögerter Freigabe

Publications (1)

Publication Number Publication Date
ATE59960T1 true ATE59960T1 (de) 1991-02-15

Family

ID=11056558

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86115815T ATE59960T1 (de) 1986-03-03 1986-11-14 Theophyllintabletten mit verzoegerter freigabe.

Country Status (7)

Country Link
US (1) US4795645A (de)
EP (1) EP0235363B1 (de)
JP (1) JPH06104625B2 (de)
AT (1) ATE59960T1 (de)
CA (1) CA1276107C (de)
DE (1) DE3676997D1 (de)
IL (1) IL78017A (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5051406A (en) * 1987-03-04 1991-09-24 Nippon Hypox Laboratories Incorporated Pharmaceutical composition using albumin as a carrier and process for producing the same
US5023080A (en) * 1988-06-17 1991-06-11 Basic Bio Systems, Inc. Time release protein
FR2650502B1 (fr) * 1989-08-07 1994-05-27 Delagrange Laboratoires Nouvelle forme galenique orale ameliorant la biodisponibilite
GB2284761A (en) * 1993-12-03 1995-06-21 Euro Celtique Sa Prophylactic treatment of asthma
DE19739031A1 (de) * 1997-09-05 1999-03-11 Suwelack Nachf Dr Otto Mittel zur peroralen Verabreichung, seine Herstellung und Verwendung
AR028986A1 (es) * 1999-02-23 2003-06-04 Smithkline Beecham Corp USO DE UN INHIBIDOR DE PDE4 EN LA FABRICACIoN DE UNA PREPARACIoN DE LIBERACIoN CONTROLADA; FORMULACION DE LIBERACION CONTROLADA PARA EL TRATAMIENTO DE COPD, UN PROCEDIMIENTO PARA SU PREPARACIoN Y COMPOSICIoN FARMACÉUTICA
US6602911B2 (en) * 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
EP1485078B1 (de) * 2002-03-15 2012-09-26 Cypress Bioscience, Inc. Milnacipran zur Behandlung von Reizdarmsyndrom
US20040132826A1 (en) * 2002-10-25 2004-07-08 Collegium Pharmaceutical, Inc. Modified release compositions of milnacipran
US20060003004A1 (en) * 2002-10-25 2006-01-05 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
AU2004207578B2 (en) * 2003-01-28 2007-06-28 Collegium Pharmaceutical, Inc. Multiparticulate compositions of milnacipran for oral administration
US7994220B2 (en) * 2005-09-28 2011-08-09 Cypress Bioscience, Inc. Milnacipran for the long-term treatment of fibromyalgia syndrome
US20110268666A1 (en) * 2008-09-29 2011-11-03 Yissum Research Development Company of the Research University of Jerusalem, Ltd. Novel gastroretentive delivery system
US20130040982A1 (en) * 2010-04-22 2013-02-14 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Oral sustained release formulation of huperzine a
CN116966157B (zh) * 2023-09-22 2024-02-09 山东则正医药技术有限公司 一种茶碱缓释片及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE636568A (de) * 1961-01-31
US3922379A (en) * 1973-12-17 1975-11-25 Abbott Lab Microencapsulation process
US4002756A (en) * 1974-04-22 1977-01-11 Interx Research Corporation Useful pro-drug forms of theophylline
US4147167A (en) * 1976-08-05 1979-04-03 Horst R. Hickmann Ophthalmic prosthesis implant instrument
US4223031A (en) * 1978-05-05 1980-09-16 Mead Johnson & Company Azolopyrimidinones
JPS55153715A (en) * 1979-05-18 1980-11-29 Nikken Kagaku Kk Prolonged granule of theophylline
DE3104815C2 (de) * 1980-02-13 1983-07-07 Japan Atomic Energy Research Institute, Tokyo Verfahren zur Herstellung eines Verbundstoffs mit Langzeit-Freigabe
JPS6042205B2 (ja) * 1980-12-22 1985-09-20 日本原子力研究所 徐放性複合体の製造方法
US4465660A (en) * 1981-04-01 1984-08-14 Mead Johnson & Company Sustained release tablet containing at least 95 percent theophylline
ZA836031B (en) * 1983-08-16 1985-02-27 Verex Lab Constant release rate solid dosage theophylline formulation
US4695591A (en) * 1985-03-29 1987-09-22 Schering Corporation Controlled release dosage forms comprising hydroxypropylmethylcellulose
US4710384A (en) * 1986-07-28 1987-12-01 Avner Rotman Sustained release tablets made from microcapsules

Also Published As

Publication number Publication date
DE3676997D1 (de) 1991-02-21
JPH06104625B2 (ja) 1994-12-21
EP0235363A3 (en) 1987-11-19
IL78017A0 (en) 1986-07-31
CA1276107C (en) 1990-11-13
US4795645A (en) 1989-01-03
IL78017A (en) 1989-06-30
JPS62207217A (ja) 1987-09-11
EP0235363B1 (de) 1991-01-16
EP0235363A2 (de) 1987-09-09

Similar Documents

Publication Publication Date Title
ATE59960T1 (de) Theophyllintabletten mit verzoegerter freigabe.
CS410191A3 (en) Benzimidazoles, process of their preparation and medicaments comprising said compounds
PT84359A (en) Process for the preparation of granules containing an active substance and to the use thereof as speckles for treating substrates
MY104065A (en) New pharmaceutical preparation
DE2966497D1 (en) 6-, 1- and 2-substituted-1-carbapen-2-em-3-carboxylic acids, processes for the preparation of such compounds and pharmaceutical composition comprising such compounds
HUT41642A (en) Process for producing tablets of regulated dissolution of the active agents
DE2960292D1 (en) 17-beta-thiocarboxylic acid esters of 4-halo-3-oxoandrost-4-enes, their pharmaceutical use and processes for their preparation
NO874869L (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO841518L (no) Delbare tabletter med forsinket frigjoering av virkestoff, og fremgangsmaate for fremstilling derav
NO178619C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive di-t-butylfenoler
ZA871657B (en) Process for the preparation of medicament adsorbates
IS1565B (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
NO176273C (no) Analogifremgangsmåte for fremstilling av aktive substituerte benzamider
NO883750D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater.
DE3062981D1 (en) Alkyl-urea derivatives for the treatment of lipometabolic diseases; process for their preparation, their use in medicaments for the treatment of lipometabolic disorders, medicaments containing them, process for the preparation of the medicaments, and some alkyl-urea derivatives
JPS5572117A (en) Analgesic tablet and its manufacture
HUT46837A (en) Compositions of insectifuge and acarifuge activity containing alpha, omega-amino-alkohol derivatives as active components and process for producing the active components
ZA837332B (en) Novel galenic form of sulpiride,process for its preparation and medicament comprising said novel form
MX9202366A (es) Nuevas 2-amino-5-ciano-1,4-di hidro piridinas y procedimiento para su fabricacion.
EP0270682A4 (de) Neue komplexe deren herstellung und verwendung als arzneimittel.
GR61598B (en) Disubstituted phenolethers of 3-amino-2-hydroxypropan,preparation process thereof and use thereof as medicines
ZA812362B (en) Monohydrated isophthalic acid picolylamide, process of preparation and pharmaceutical use thereof
NO163327C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydropyridiner.
ES2039386T3 (es) Procedimiento para preparar oxolabdanos y su utilizacion para preparar medicamentos.
IT8067731A0 (it) Preparato medicinale per trattare carcinomi e procedimento per la suaproduzione

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties